Safety and proof-of-concept efficacy of inhaled drug loaded nano- and immunonanoparticles in a c-Raf transgenic lung cancer model. [electronic resource]
Producer: 20130625Description: 11-29 p. digitalISSN:- 1873-5576
- Administration, Inhalation
- Animals
- Antibodies, Immobilized -- administration & dosage
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Neoplasm -- administration & dosage
- Antigens, Neoplasm -- metabolism
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Cell Adhesion Molecules -- antagonists & inhibitors
- Disease Models, Animal
- Drug Delivery Systems -- adverse effects
- Epithelial Cell Adhesion Molecule
- Female
- Humans
- Lung -- drug effects
- Lung Neoplasms -- drug therapy
- Male
- Mice
- Mice, Transgenic
- Nanoparticles -- administration & dosage
- Paclitaxel -- administration & dosage
- Palmitates -- administration & dosage
- Proto-Oncogene Proteins c-raf -- genetics
- Random Allocation
- Surface Properties
- Survival Analysis
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.